How Fundamental Research on T cell Biology Started a Revolution in Cancer Therapy Development

Authors

  • Tristan Mula University of Alberta

DOI:

https://doi.org/10.29173/eureka28822

Keywords:

immunotherapy, T cell biology, checkpoint blockade, thymus, foundational research, CAR T cell therapy, spontaneous tumour regression

Abstract

In the dynamic landscape of cancer treatment, discovery-based research in T cell biology has proven transformative, ushering in revolutionary immunotherapies. This paper navigates the impact of fundamental research on cancer therapy, tracing its evolution from 19th-century trailblazers Wilhelm Busch and Friedrich Fehleisen to recent breakthroughs by James P. Allison. By understanding T cells, the immune system's superheroes, we can illuminate the pivotal role of selectively targeting and eliminating cancer cells with unprecedented precision. Advances such as checkpoint blockade antibodies have freed tumor-infiltrating T cells from inhibition, allowing them to kill tumor cells effectively. This was a revolutionary breakthrough. Historical insights, such as the discovery of immunocompetent recirculating lymphocytes and the function of the thymus, laid the groundwork for these advances. This ongoing dialogue on resource allocation recognizes foundational research as the cornerstone for innovative therapies, ensuring a sustainable pipeline of discoveries that shape the future of T cell cancer treatment.

Downloads

Download data is not yet available.

References

Allison, J. P. (2018, December). Immune Checkpoint Blockade in Cancer Therapy . Nobel Lecture. San Francisco; California .

Boorman, G. A., & Everitt, J. I. (2006). Neoplastic disease. The Laboratory Rat, 479–511. https://doi.org/10.1016/b978-012074903-4/50017-0

Cleveland Clinic medical professional (Ed.). (2023, January 17). T cells: Types and function. Cleveland Clinic. https://my.clevelandclinic.org/health/body/24630-t-cells

Ferretti, J., & Köhler, W. (2016). History of Streptococcal Research. In Streptococcus pyogenes: Basic Biology to Clinical Manifestations. University of Oklahoma Health Sciences Center, Oklahoma City (OK). PMID: 26866232.

Gowans, J. L., McGREGOR, D. D., COWEN, D. M., & FORD, C. E. (1962). Initiation of immune responses by small lymphocytes. Nature, 196(4855), 651–655. https://doi.org/10.1038/196651a0

Hoyne, A. L., Wolf, A. A., & Prim, L. (1939). Fatality rates in the treatment of 998 Erysipelas patients. Journal of the American Medical Association, 113(26). https://doi.org/10.1001/jama.1939.02800510001001

Hudson, D., Fernandes, R. A., Basham, M., Ogg, G., & Koohy, H. (2023). Can we predict T cell specificity with digital biology and machine learning? Nature Reviews Immunology, 23(8), 511–521. https://doi.org/10.1038/s41577-023-00835-3

Johnson, L. A. (2021). In sickness and in health: The immunological roles of the lymphatic system. International Journal of Molecular Sciences, 22(9), 4458. https://doi.org/10.3390/ijms22094458

Kaufmann, S. H. (2019). Immunology’s coming of age. Frontiers in Immunology, 10. https://doi.org/10.3389/fimmu.2019.00684

McCarthy E. F. (2006). The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. The Iowa orthopaedic journal, 26, 154–158.

Miller, J. F. A. P. (2004). Events that led to the discovery of t‐cell development and function – a personal recollection. Tissue Antigens, 63(6), 509–517. https://doi.org/10.1111/j.0001-2815.2004.00255.x

Miller, J. F. A. P. (2011). The Golden Anniversary of the Thymus. Nature Reviews Immunology, 11(7), 489–495. https://doi.org/10.1038/nri2993

Miller, J. F. A. P., & Sadelain, M. (2015). The journey from discoveries in fundamental immunology to cancer immunotherapy. Cancer Cell, 27(4), 439–449. https://doi.org/10.1016/j.ccell.2015.03.007

Mitra, A., Barua, A., Huang, L., Ganguly, S., Feng, Q., & He, B. (2023). From bench to bedside: The history and progress of car T cell therapy. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1188049

Pappas, G., Kiriaze, I. J., & Falagas, M. E. (2008). Insights into infectious disease in the era of Hippocrates. International Journal of Infectious Diseases, 12(4), 347–350. https://doi.org/10.1016/j.ijid.2007.11.003

Pardoll, D. M. (2012). Immunology beats cancer: A blueprint for successful translation. Nature Immunology, 13(12), 1129–1132. https://doi.org/10.1038/ni.2392

Rasheed, A. A., & Koyyala, V. P. (2021). Chimeric antigen receptor T-cell therapy. Indian Journal of Medical and Paediatric Oncology, 42(01), 089–092. https://doi.org/10.1055/s-0041-1729437

Říhová, B., & Šťastný, M. (2015). History of immunotherapy – from Coley toxins to checkpoints of the immune reaction. Klinicka Onkologie, 28(Suppl 4). https://doi.org/10.14735/amko20154s8

Vogelzang, A., McGuire, H. M., Yu, D., Sprent, J., Mackay, C. R., & King, C. (2008). A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity, 29(1), 127–137. https://doi.org/10.1016/j.immuni.2008.06.001

Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020). A guide to cancer immunotherapy: From T cell basic science to clinical practice. Nature Reviews Immunology, 20(11), 651–668. https://doi.org/10.1038/s41577-020-0306-5

Wallersteiner, R. (2020). James Gowans: Immunologist whose research revealed the crucial role of lymphocytes in the immune response. BMJ, m2190. https://doi.org/10.1136/bmj.m2190

Zhang, Y., & Zhang, Z. (2020, July 1). The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Nature News. https://www.nature.com/articles/s41423-020-0488-6

Downloads

Published

2024-05-29

How to Cite

Mula, T. (2024). How Fundamental Research on T cell Biology Started a Revolution in Cancer Therapy Development. Eureka, 9(1). https://doi.org/10.29173/eureka28822

Issue

Section

Reviews